These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Epidemiological investigation of beta-lactam antibiotic induced vancomycin-resistant MRSA from clinical isolated MRSA--comparison of detection rate of BIVR with or without CZX]. Hososaka Y; Hanaki H; Hayashi I; Kamibeppu K; Sunakawa K Kansenshogaku Zasshi; 2004 Aug; 78(8):717-21. PubMed ID: 15478647 [TBL] [Abstract][Full Text] [Related]
25. Experimental study on the efficacy of combinations of glycopeptides and beta-lactams against Staphylococcus aureus with reduced susceptibility to glycopeptides. Domenech A; Ribes S; Cabellos C; Taberner F; Tubau F; Domínguez MA; Montero A; Liñares J; Ariza J; Gudiol F J Antimicrob Chemother; 2005 Oct; 56(4):709-16. PubMed ID: 16120625 [TBL] [Abstract][Full Text] [Related]
26. Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy. Sakoulas G; Moellering RC; Eliopoulos GM Clin Infect Dis; 2006 Jan; 42 Suppl 1():S40-50. PubMed ID: 16323119 [TBL] [Abstract][Full Text] [Related]
27. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus. Charles PG; Ward PB; Johnson PD; Howden BP; Grayson ML Clin Infect Dis; 2004 Feb; 38(3):448-51. PubMed ID: 14727222 [TBL] [Abstract][Full Text] [Related]
28. Introduction: Solving the clinical problem of vancomycin resistance. Moellering RC; Ferraro MJ Clin Infect Dis; 2012 Apr; 54 Suppl 3():S201-2. PubMed ID: 22431849 [No Abstract] [Full Text] [Related]
29. Update on emerging infections: news from the Centers for Disease Control and Prevention. Moran GJ; Mount J Ann Emerg Med; 2003 Jan; 41(1):148-51. PubMed ID: 12514697 [No Abstract] [Full Text] [Related]